Discover how advancing HER2 science is reshaping cancer care. By deepening understanding of tumor complexity and leveraging biomarker-driven approaches, we are enabling more precise therapies and driving innovation to improve outcomes for patients with HER2-expressing cancers and other areas of high unmet need.
Amal Melhem-Bertrandt, Vice President and Oncology Therapy Area Head, Research and Development, sheds light on gastroesophageal adenocarcinoma (GEA) and the significant impact it has on both life expectancy and quality of life for people living with this difficult-to-treat cancer.
Rob Iannone, Executive Vice President, Global Head of Research and Development and Chief Medical Officer, discusses the biology of HER2 expressing or amplified cancers and how identifying these HER2 amplifications can guide more targeted treatment approaches for patients.
Increased understanding around HER2 biology is helping to shape the future of cancer care. Amal Melhem-Bertrandt, Vice President and Oncology Therapy Area Head, Clinical Research and Development, discusses the importance of leveraging biomarker strategies for developing therapies that effectively target HER2-expressing cancers.
Chumi Khurana, Senior Vice President and Oncology Franchise Head, shares insights into our oncology strategy and ongoing commitment to advancing science in rare cancers across solid tumors, neuro-oncology and hematologic malignancies.
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
